Naprometin (Naproxen)

Naproxen, the active ingredient in Naprometin, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for mild to moderate pain, arthritis and fever in adults.

GNH USA supplies Naprometin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen acts systemically to reduce inflammation and pain across several common conditions.

- Mild to moderate pain: provides analgesic relief for acute or chronic pain states. - Osteoarthritis: reduces joint inflammation and improves mobility. - Rheumatoid arthritis: helps control inflammatory activity and pain. - Dysmenorrhea: alleviates menstrual cramping and associated discomfort. - Fever: lowers elevated body temperature in febrile episodes.

Adverse reactions may range from mild to serious and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: dyspepsia, abdominal discomfort. - Nausea or vomiting. - Headache. - Dizziness. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Acute renal impairment. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic injury. - Anaphylactic or severe allergic reactions.

Before initiating therapy, consider the following safety measures.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: especially in patients with dehydration or pre‑existing kidney disease. - Evaluate cardiovascular status: use caution in patients with heart disease. - Use the lowest effective dose for the shortest duration needed. - Avoid in individuals with known hypersensitivity to naproxen or other NSAIDs. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Naproxen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion. - Diuretics: potential for decreased renal function and electrolyte imbalance.